Few neuropsychiatric syndromes among children and adolescents generate
as much professional, parental, and public concern as has attention-deficit/hyperactivity
disorder. In this report from the AMA Council on Scientific Affairs, Dr Goldman
and colleagues present a thorough evaluation of the epidemiology, diagnostic
criteria, clinical course, and pharmacologic treatment of this relatively
common yet controversial syndrome.